Pandemic Vaccines Probably Can’t Use Accelerated Approval – US FDA Chief Scientist

That’s not because the agency doesn’t want to get products cleared as fast as possible, Luciana Borio says; it’s because the pathway remains elusive for many pandemic treatments in the absence of surrogates due to largely undeveloped science.

Zika Mosquito

A lack of developed science has highlighted the difficulty of speeding up pandemic vaccine development, such as for Zika and Ebola, FDA officials and industry representatives say.

Luciana Borio, FDA’s acting chief scientist, said the issue has been evident as an obstacle for sponsors in obtaining accelerated...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet